Evaluating BCG Therapy in High- and Low-Grade Non-Muscle-Invasive Bladder Cancer: Insights from a Latvian Hospital (2019–2024)
By:
Authors
Reičela Heinrihsone
Department of Biology and Microbiology, Rīga Stradiņš University, Rīga, Latvia
Maksimilians Rate
Faculty of Medicine and Life Sciences, University of Latvia, Rīga, Latvia
Ērika Bitiņa-Barlote
Institute of Oncology and Molecular Genetics, Rīga Stradiņš University, Rīga, Latvia
Department of Urology, Pauls Stradiņš Clinical University Hospital, Latvia
Juris Plonis
Institute of Oncology and Molecular Genetics, Rīga Stradiņš University, Rīga, Latvia
Department of Urology, Pauls Stradiņš Clinical University Hospital, Latvia
Edvīns Miklaševičs
Department of Biology and Microbiology, Rīga Stradiņš University, Rīga, Latvia
Miki Nakazawa-Miklaševiča
Department of Biology and Microbiology, Rīga Stradiņš University, Rīga, Latvia
Institute of Oncology and Molecular Genetics, Rīga Stradiņš University, Rīga, Latvia
Language: English
Page range: 198 - 204
Submitted on: May 26, 2025
Accepted on: Aug 12, 2025
Published on: Sep 27, 2025
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 6 times per year
Keywords:
Related subjects:
© 2025 Reičela Heinrihsone, Maksimilians Rate, Ērika Bitiņa-Barlote, Juris Plonis, Edvīns Miklaševičs, Miki Nakazawa-Miklaševiča, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons Attribution 4.0 License.